These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 7952654

  • 1. Structure-function relationships in the tissue inhibitors of metalloproteinases.
    Willenbrock F, Murphy G.
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S165-70. PubMed ID: 7952654
    [Abstract] [Full Text] [Related]

  • 2. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
    Nguyen Q, Willenbrock F, Cockett MI, O'Shea M, Docherty AJ, Murphy G.
    Biochemistry; 1994 Mar 01; 33(8):2089-95. PubMed ID: 8117665
    [Abstract] [Full Text] [Related]

  • 3. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 4. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.
    Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJ, Cockett MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G.
    Biochemistry; 1993 Apr 27; 32(16):4330-7. PubMed ID: 8476862
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human stromelysin by peptides based on the N-terminal domain of tissue inhibitor of metalloproteinases-1.
    Hanglow AC, Lugo A, Walsky R, Visnick M, Coffey JW, Fotouhi N.
    Biochem Biophys Res Commun; 1994 Dec 15; 205(2):1156-63. PubMed ID: 7802645
    [Abstract] [Full Text] [Related]

  • 6. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions.
    Butler GS, Apte SS, Willenbrock F, Murphy G.
    J Biol Chem; 1999 Apr 16; 274(16):10846-51. PubMed ID: 10196161
    [Abstract] [Full Text] [Related]

  • 7. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.
    Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911
    [Abstract] [Full Text] [Related]

  • 8. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin.
    Baragi VM, Fliszar CJ, Conroy MC, Ye QZ, Shipley JM, Welgus HG.
    J Biol Chem; 1994 Apr 29; 269(17):12692-7. PubMed ID: 8175679
    [Abstract] [Full Text] [Related]

  • 9. Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13.
    O'Shea M, Willenbrock F, Williamson RA, Cockett MI, Freedman RB, Reynolds JJ, Docherty AJ, Murphy G.
    Biochemistry; 1992 Oct 27; 31(42):10146-52. PubMed ID: 1420137
    [Abstract] [Full Text] [Related]

  • 10. TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.
    Stetler-Stevenson WG, Krutzsch HC, Liotta LA.
    Matrix Suppl; 1992 Oct 27; 1():299-306. PubMed ID: 1480041
    [Abstract] [Full Text] [Related]

  • 11. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.
    Ward RV, Hembry RM, Reynolds JJ, Murphy G.
    Biochem J; 1991 Aug 15; 278 ( Pt 1)(Pt 1):179-87. PubMed ID: 1909113
    [Abstract] [Full Text] [Related]

  • 12. Dynamic characterisation of the netrin-like domain of human type 1 procollagen C-proteinase enhancer and comparison to the N-terminal domain of tissue inhibitor of metalloproteinases (TIMP).
    Williamson RA, Panagiotidou P, Mott JD, Howard MJ.
    Mol Biosyst; 2008 May 15; 4(5):417-25. PubMed ID: 18414739
    [Abstract] [Full Text] [Related]

  • 13. Structural features of the reprolysin atrolysin C and tissue inhibitors of metalloproteinases (TIMPs) interaction.
    Pinto AF, Terra RM, Guimarães JA, Kashiwagi M, Nagase H, Serrano SM, Fox JW.
    Biochem Biophys Res Commun; 2006 Sep 01; 347(3):641-8. PubMed ID: 16842758
    [Abstract] [Full Text] [Related]

  • 14. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K.
    EMBO J; 1998 Sep 01; 17(17):5238-48. PubMed ID: 9724659
    [Abstract] [Full Text] [Related]

  • 15. Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP.
    Banda MJ, Howard EW, Herron GS, Apodaca G.
    Matrix Suppl; 1992 Sep 01; 1():294-8. PubMed ID: 1480040
    [Abstract] [Full Text] [Related]

  • 16. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases.
    Huang W, Meng Q, Suzuki K, Nagase H, Brew K.
    J Biol Chem; 1997 Aug 29; 272(35):22086-91. PubMed ID: 9268350
    [Abstract] [Full Text] [Related]

  • 17. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
    Shapiro SD, Fliszar CJ, Broekelmann TJ, Mecham RP, Senior RM, Welgus HG.
    J Biol Chem; 1995 Mar 17; 270(11):6351-6. PubMed ID: 7890773
    [Abstract] [Full Text] [Related]

  • 18. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins.
    Docherty AJ, Murphy G.
    Ann Rheum Dis; 1990 Jun 17; 49 Suppl 1():469-79. PubMed ID: 2197998
    [Abstract] [Full Text] [Related]

  • 19. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1.
    Chesler L, Golde DW, Bersch N, Johnson MD.
    Blood; 1995 Dec 15; 86(12):4506-15. PubMed ID: 8541540
    [Abstract] [Full Text] [Related]

  • 20. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions.
    Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM.
    Pharmacol Ther; 1993 Sep 15; 59(3):329-41. PubMed ID: 8309995
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.